Prostate cancer is the most common non-skin cancer among men in the United States. Every year more than 230,000 men are diagnosed with the disease, and approximately 30,000 die from it. If detected early, prostate cancer is often treatable. The five-year relative survival rate is nearly 100 percent; and at 15 years it’s 94 percent.
The majority of newly diagnosed prostate cancer is localized. In other words, the tumor growth has not spread beyond the prostate gland. Early detection allows for more treatment options to increase the chances of survival.
Prostate cancer in its early stages typically has no symptoms. Once detected, a number of treatment options may be considered in addition to active surveillance, also known as watchful waiting. Consult your physician and empower yourself with knowledge by learning about all of the available treatment options in addition to the risks, potential benefits, and side effects of each.